Cell Mapping Symposium

San Francisco, CA
September 13 & 14, 2017

The 2017 Cell Mapping Symposium will address Cell Mapping as it relates to Cancer, Psychiatric Disorders, Infectious Diseases and Technology Development. A major motivation of this symposium is the realization that although much insight has been gained from large genome sequencing projects, effort now needs to be placed on extracting mechanistic insight from these data. These efforts include using proteomic, biochemical, genetic and structural biology approaches to generate cellular maps that can be used to interpret this genomic data from a variety of different disease areas.

Confirmed Speakers:

Andrej Sali, UCSF
Dave Agard, UCSF
Jasmin Fisher, Cambridge
Jennifer Grandis, UCSF
Jeremy Willsey, UCSF
Laura van’t veer, UCSF
Mark von Zastrow, UCSF 

Martin Kampman, UCSF
Michael Bassik, Stanford
Michael Boutros, DKFZ

Nevan Krogan, UCSF and the Gladstone Institutes
Peter Jackson, Stanford
Rick Horwitz, Allen Institute
Trey Ideker, UC San Diego

Ensembl Tutorial

UC San Diego, MET Bldg, Room 141
January 11, 2018
8:30 am – 4:30 pm

Hosted by Helen Sparrow – Ensembl Outreach Officer
European Bioinformatics Institute (EMBL-EBI)
Registration begins winter 2017


Previous events:

Cancer Cell Map Initiative (CCMI) Workshop

San Francisco, CA
September 27 & 28, 2016

Two-day workshop at UC San Francisco to promote group discussion and consensus building around the goal of cancer cell network mapping. This event organized a focused group of investigators toward the ultimate challenge of assembling a complete map of the molecular network drivers of cancer. Although many of us are already working on cancer networks, coordination between teams is immensely beneficial in defining and developing the various network types and conditions (cell lines, tissues, environments) that will be required. It is also important to plan how such network maps can be developed into pathway models and used for interpretation of patient genomic data, thus enabling “precision medicine.”